Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 8c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.64), $0.08 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Trio-Tech wins $4.7M automotive semiconductor burn-in contract
• Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)